Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

From Pfizer, Inc.

The funder's mission is to improve outcomes for patients with advanced prostate cancer and to advance research, innovation, clinical expertise, and education for healthcare professionals in Latin America.

Type of Support

Overview

This competitive grant program aims to support local-level educational activities for healthcare professionals involved in treating heart failure patients at risk for TTR Amyloidosis. It encourages organizations to identify and address the educational needs of these professionals to enhance awareness and facilitate early and appropriate patient identification through an evidence-based approach. Applications are accepted on a rolling basis until funds are depleted.

Eligibility

Organization's Location
ex enim
Program Location
sunt
Organization Type
10k – 20k

Submission

Visit Apply for more information.

Similar grants